Literature DB >> 1735494

The relative distribution of viable sperm in the antegrade and retrograde portions of ejaculates obtained after electrostimulation.

I H Hirsch1, J Sedor, R S Jeyendran, W E Staas.   

Abstract

OBJECTIVE: To determine the relative concentration, motility, and viability of spermatozoa in the antegrade and retrograde portions of the ejaculate after electroejaculation in spinal cord injured men.
DESIGN: Retrospective.
SETTING: University outpatient clinic providing tertiary care in reproductive rehabilitation. PATIENTS: The antegrade and retrograde portions of 22 ejaculates obtained from five spinal cord-injured men were analyzed for sperm density, mean sperm motility, and percentage of total motile and viable sperm yield.
RESULTS: The number of spermatozoa were uniformly distributed between the antegrade (54.4%) and retrograde (45.6%) ejaculates. However, of the total sperm yield in both compartments, 66.3% of the motile spermatozoa and 71% of the viable sperm were found in the antegrade compartment (P less than 0.05). Additionally, mean sperm motility was significantly higher in the antegrade ejaculate (P less than 0.05).
CONCLUSIONS: Significantly impaired sperm motility and viability are noted in the retrograde ejaculate. Efforts should therefore be directed to maximizing the antegrade portion of the electro-ejaculate and optimizing the technique of preserving functional sperm in the intravesical compartment.

Entities:  

Mesh:

Year:  1992        PMID: 1735494

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Measurement of sexual functioning after spinal cord injury: preferred instruments.

Authors:  Marcalee Sipski Alexander; Nancy L Brackett; Donald Bodner; Stacy Elliott; Amie Jackson; Jens Sonksen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

Review 2.  Fertility treatment in spinal cord injury and other neurologic disease.

Authors:  Vera Trofimenko; James M Hotaling
Journal:  Transl Androl Urol       Date:  2016-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.